Tobias Gedde-Dhl
Welcome,         Profile    Billing    Logout  
 4 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tjønnfjord, Geir
CLL17, NCT04608318 / 2019-003854-99: Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients with Previously Untreated Chronic Lymphocytic Leukaemia (CLL)

Active, not recruiting
3
897
Europe, RoW
Ibrutinib, Imbruvica, Venetoclax, ABT-199, Venclyxto, Obinutuzumab, GA101, Gazyvaro
German CLL Study Group, Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Nordic CLL Study Group (NCLLSG), Swiss Group for Clinical Cancer Research (SAKK), Cancer Trials Ireland, Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA), Grupo Español de Leucemia Linfocítica Crónica (GELLC), The Israeli CLL Study Group (ICLLSG), Janssen Pharmaceutica N.V., Belgium, AbbVie, Hoffmann-La Roche
Chronic Lymphoid Leukemia
09/27
09/27
Iversen, Per
CARRDIP20, NCT05030922: Cardiovascular Risk Reduction-Diet in Pregnancy - Follow up 20 Years After the "CARRDIP"-Trial

Recruiting
N/A
538
Europe
Antiatherogenic diet
Per Ole Iversen, MD, Oslo University Hospital
Nutrition
12/25
06/26
NCT06003660: Brain Neuronal Networks, Chemosensory and Trigeminal Functions in Allo-HSCT

Recruiting
N/A
70
Europe
University of Oslo
Hematopoietic Stem Cell Transplantation
12/24
06/25
NCT05269225: Organic Diet in Pregnancy and Risk Markers of Health Effects (The OrgDiet Project)

Recruiting
N/A
100
Europe
Organic diet, Conventional diet, Control
Per Ole Iversen, MD, Oslo University Hospital
Nutrition
12/24
12/25
Gedde-Dahl, Tobias
BosuPeg, NCT03831776: Long-acting Low Dose Ropeginterferon for Chronic Myeloid Leukemia Treated With Bosutinib From Diagnosis

Recruiting
2
212
Europe
Bosutinib, Ropeginterferon, RoPegIFN
St. Olavs Hospital, Haukeland University Hospital, Oslo University Hospital, University Hospital of North Norway, Helse Stavanger HF, Henri Mondor University Hospital, Hôpital René Huguenin, Hôpital Mignot, Versailles Paris, Uppsala University Hospital, Odense University Hospital
Chronic Myeloid Leukemia
02/24
03/28
DSC-BROMS-1, NCT04118556: Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease After Allo-HSCT

Recruiting
2
50
Europe
Decidua Stroma Cells (DSC), Best available Treatment (BAT), ECP, Everolimus, Sirolimus, Etanercept, Vedolizumab, Ruxolitinib, Infliximab.
Mats Remberger, The Swedish Research Council
GVHD, Acute
12/26
12/31

Download Options